NCT07664579 Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
| NCT ID | NCT07664579 |
| Status | Recruiting |
| Phase | — |
| Sponsor | City of Hope Medical Center |
| Condition | Anatomic Stage IV Breast Cancer AJCC v8 |
| Study Type | OBSERVATIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-07-05 |
| Primary Completion | 2026-11-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 160 participants in total. It began in 2024-07-05 with a primary completion date of 2026-11-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates how useful and acceptable the components of the "Couples Coping Together Against Cancer", referred to as "The Program", are to the participants with cancer.
Eligibility Criteria
Inclusion Criteria: * Have received a diagnosis of a primary brain tumor (glioblastoma), or other cancers (breast, lung, etc.) * Are new patients to City of Hope (COH) (all sites) or receive at least some of their care at City of Hope- Duarte Campus (care is defined as: procedures, consults, laboratories, imaging, surgery, and/or treatment) * The patient is in a committed relationship/partnership with a partner and the partner is available and willing to participate * Are English or Spanish speaking * ≥ 18 years of age * Have access to a smartphone, computer/laptop or internet connection to complete all study procedures Exclusion Criteria: * Significant cognitive impairment * Inpatient psychiatric treatment for severe mental illness or overt signs of severe psychopathology (e.g., psychosis) * Visual, hearing, voice, or motor impairment that prevents completion of study procedures as evidenced by clinical judgment * Committed partners will be excluded from the study if they: * Refuse to complete informed consent * Have cognitive impairment * Have severe mental illness that would prevent informed consent and completion of study activities as evidenced by clinical judgment
Contact & Investigator
William Dale
PRINCIPAL INVESTIGATOR
City of Hope Medical Center
Frequently Asked Questions
Who can join the NCT07664579 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anatomic Stage IV Breast Cancer AJCC v8. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07664579 currently recruiting?
Yes, NCT07664579 is actively recruiting participants. Visit ClinicalTrials.gov or contact City of Hope Medical Center to inquire about joining.
Where is the NCT07664579 trial being conducted?
This trial is being conducted at Duarte, United States.
Who is sponsoring the NCT07664579 clinical trial?
NCT07664579 is sponsored by City of Hope Medical Center. The principal investigator is William Dale at City of Hope Medical Center. The trial plans to enroll 160 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.